To facilitate our fresh human tissue-based drug discovery service offerings, REPROCELL have spent over 20 years developing our network of clinical partner sites and collaborators.
Looking forward, we plan to continue investing in our tissue network to meet the growing safety and efficacy requirements of drug development programs and medicine regulators around the globe.
The ultimate goal - to help bring new and improved biologically relevant treatment options to patients.